Skip to main content
WST
NYSE Industrial Applications And Services

West Pharma Beats Q3, Lifts FY26 EPS Guidance to $9.38-$9.48 and Sales to $3.41B-$3.42B

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$410.95
Mkt Cap
$28.406B
52W Low
$223.83
52W High
$404.985
52W Position info
84% above low
Off High info
at 52W high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

WST sits 84% above its 52-week low of $223.83.

Summary

West Pharmaceutical beat Q3 expectations with 11.9% organic sales growth and $2.66 adjusted EPS, then raised full-year 2026 guidance to $9.38-$9.48 adjusted EPS on $3.41-$3.42 billion in sales.


Key Events · Earnings and Guidance · WST

  • Q3 Beat With 11.9% Organic Growth

    Net sales of $874.5 million rose 8.7% reported and 11.9% organic; adjusted-diluted EPS of $2.66 rose 35.7% year over year.

  • Full-Year Guidance Raised Sharply

    FY26 adjusted-diluted EPS guidance lifted to $9.38-$9.48 from $8.85-$9.05, and net sales guidance to $3.41-$3.42 billion from $3.345-$3.380 billion.

  • HVP Components Drive the Mix

    HVP Components net sales of $466.7 million grew 19.7% reported and 20.3% organic, reaching 53% of total company net sales.

  • Buybacks and Dividend Increased

    The company repurchased $231 million of stock in the quarter ($685 million year to date) and raised the quarterly dividend 18% to $0.26 per share.


Analysis · WST · Industrial Applications And Services

West delivered an 11.9% organic sales quarter and 35.7% adjusted EPS growth, then raised full-year guidance by roughly $0.50 at the EPS midpoint and about $50 million at the sales midpoint. The raise is the story: it tells investors the HVP Components franchise (up 20.3% organic, 53% of sales) is still compounding faster than the base business, and that the May cyber incident did not dent the trajectory. Against a stock trading near its 52-week high, the risk is that expectations were already high, so the size of the beat and raise — not just the direction — is what matters.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, WST was trading at $410.95 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $28.4B. The 52-week trading range was $223.83 to $404.99. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WST - Latest Insights

WST
Oct 29, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $416.67
Real-time Price: $413.14 info
Change: -$3.54 (-0.85%) info
Market Cap: $28.779B info
WST
Oct 29, 2026, 7:04 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $410.95
Real-time Price: $413.14 info
Change: +$2.19 (+0.53%) info
Market Cap: $28.779B info
WST
Oct 29, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $398.00
Real-time Price: $413.14 info
Change: +$15.13 (+4%) info
Market Cap: $28.779B info
WST
Jul 23, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $354.08
Real-time Price: $413.14 info
Change: +$59.06 (+17%) info
Market Cap: $28.779B info
WST
Jul 23, 2026, 7:14 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $380.00
Real-time Price: $413.14 info
Change: +$33.13 (+9%) info
Market Cap: $28.779B info